Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-191
Closed -$182K 2704
2022
Q1
$182K Hold
191
﹤0.01% 2696
2021
Q4
$363K Buy
191
+56
+41% +$133K ﹤0.01% 2640
2021
Q3
$424K Hold
135
﹤0.01% 2552
2021
Q2
$437K Buy
+135
New +$610K ﹤0.01% 2578
2014
Q3
Sell
-14
Closed -$53K 2567
2014
Q2
$53K Sell
14
-200
-93% -$815K ﹤0.01% 2552
2014
Q1
$1.21M Hold
214
﹤0.01% 1506
2013
Q4
$1.21M Hold
214
﹤0.01% 1453
2013
Q3
$1.91M Buy
214
+203
+1,845% +$1.64M ﹤0.01% 1267
2013
Q2
$73K Buy
+11
New +$77.8K ﹤0.01% 2429

Other funds holding CRIS

UBS AM's CRIS Position: Q2 2022 in Review

UBS AM sold out of Curis (CRIS) in Q2 2022, closing a stake of 191 shares — an estimated $182K sold.

UBS AM first reported a position in CRIS in Q2 2013 and held it in 9 quarters. The position peaked at $1.91M in Q3 2013. 86 funds tracked by Wall St. Rank hold CRIS as of Q2 2022.

  • UBS AM reported no remaining Curis position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 191 Curis shares in Q2 2022, an estimated $182K.
  • UBS AM first reported a position in Curis in Q2 2013 and held it in 9 quarters.
  • UBS AM's Curis position peaked at $1.91M in Q3 2013.
  • 86 funds tracked by Wall St. Rank held Curis as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.